Replies to post #93118 on Ayala Pharmaceuticals Inc (ADXS)

[hdwrsft]

Ruh-roh....4 more years of this????.......ugh.

[hovacre]

Well, for what it's worth, the important results should be known much sooner than 4 years from now. That doesn't change their cash situation, of course.

[DewDiligence]

ADXS did not even get free Keytruda…are they expecting Merck to sign up for this?

Seems likely; Merck furnishes free Keytruda for many phase-1/2 trials testing Keytruda plus another agent. Note that Keytruda doesn’t come into play until the ADXS-503 monotherapy dose-escalation portion of the trial is completed.